MedTrace Logo

Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection

NCT05724368 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2023-02-13

No results posted yet for this study

Summary

Blastocystis which is commonly found in the gastro-intestinal tract, has been recognized as a non-pathogenic organism for a few decades. It has a variable distribution. A high prevalence has been reported in developing countries (22.1-100%).

In developed countries, the prevalence ranges from 0.5% to 23.1%. The high prevalence noted in developing countries is related to poor hygiene and lack of safe water and food .

Conditions

  • Blastocystis Infections

Interventions

DIAGNOSTIC_TEST

Fecal Calprotectin ELISA kit

* Routine stool examination will be done in addition to certain concentration, staining and culture techniques. * Fecal calprotectin will be evaluated using ELISA kits according to the manufacturer's instructions.

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-03-31
Primary Completion
2024-03-31
Completion
2025-03-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05724368 on ClinicalTrials.gov